Promising trials of malaria vaccine lead to calls for Phase 3 development
Tuesday, December 9, 2008 - 01:23
in Health & Medicine
Experts are recommending that a malaria vaccine progress to Phase 3 trials following the successful trial of the RTS, S/AS01E malaria vaccine among 5-17 month old children in Korogwe, Tanzania and coastal Kenya, which is reported today in the New England Journal of Medicine (NEJM).